See All Slides - tctmd.com

Slides

Presentation TCT 2015

Independent Bench Comparison of Different Bioresorbable Scaffolds

Presenter: Elazer R. Edelman, Juan F. Granada, John A. Ormiston

October 14, 2015

Presentation TCT 2015

I Would Treat This Patient Conservatively (Medications First)

Presenter: Robert O. Bonow, Ajay J. Kirtane, Mark Goldberger

October 14, 2015

Presentation TCT 2015

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? Another Failed NIH-Funded Study: CREST-2 Is CORAL Redux (or Worse)!

Presenter: William A. Gray, D. Christopher Metzger

October 14, 2015

Presentation TCT 2015

Implications of Tricuspid Regurgitation and/or Severe Pulmonary Hypertension in Patients Undergoing MV Surgery or MitraClip

Presenter: Stephan Baldus, Saibal Kar, Jason H. Rogers

October 14, 2015

Presentation TCT 2015

Update on the ROPE Study: Emerging Insights

Presenter: John D. Carroll, Mark Reisman, David E. Thaler

October 14, 2015

Presentation TCT 2015

Rivaroxaban: Analysis of Efficacy, Safety, and Special Considerations

Presenter: Lisa K. Jennings, Matthew T. Roe, Manesh R. Patel

October 14, 2015

Presentation TCT 2015

Has the Proximal Optimization Technique (POT) Become Essential? Heres Why

Presenter: Antonio L. Bartorelli, Yves R. Louvard, Massoud A. Leesar

October 14, 2015

Presentation TCT 2015

BRS Mechanical Properties, Conformability, and Other Insights From Bench Studies

Presenter: Elazer R. Edelman, Juan F. Granada, Nicolas Foin

October 14, 2015

Presentation TCT 2015

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? The CREST-2 Trial Is the Right Trial at the Right Time!

Presenter: William A. Gray, D. Christopher Metzger, Gary S. Roubin

October 14, 2015

Presentation TCT 2015

ASD After MitraClip: Is This the Smoking Gun?

Presenter: Stephan Baldus, Saibal Kar, Michael J. Lim

October 14, 2015

Advertisement

Slides

Independent Bench Comparison of Different Bioresorbable Scaffolds

I Would Treat This Patient Conservatively (Medications First)

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? Another Failed NIH-Funded Study: CREST-2 Is CORAL Redux (or Worse)!

Implications of Tricuspid Regurgitation and/or Severe Pulmonary Hypertension in Patients Undergoing MV Surgery or MitraClip

Update on the ROPE Study: Emerging Insights

Rivaroxaban: Analysis of Efficacy, Safety, and Special Considerations

Has the Proximal Optimization Technique (POT) Become Essential? Heres Why

BRS Mechanical Properties, Conformability, and Other Insights From Bench Studies

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? The CREST-2 Trial Is the Right Trial at the Right Time!

ASD After MitraClip: Is This the Smoking Gun?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content